Cargando…
Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma
OBJECTIVES: Multimodal kidney‐preserving (MKP) strategies may be an option for patients with localised or locally advanced high‐risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU). MATERIALS AND METHODS: We studied patients with UTUC who were...
Autores principales: | Alhalabi, Omar, Campbell, Matthew T., Xiao, Lianchun, Adriazola, Ana C., Wilson, Nathaniel R., Siefker‐Radtke, Arlene O., Corn, Paul G., Zurita, Amado, Jonasch, Eric, Gao, Jianjun, Adibi, Mehrad, Kamat, Ashish M., Navai, Neema, Pisters, Louis L., Dinney, Colin, Matin, Surena F., Shah, Amishi Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988842/ https://www.ncbi.nlm.nih.gov/pubmed/35475152 http://dx.doi.org/10.1002/bco2.113 |
Ejemplares similares
-
Erdafitinib for locally advanced or metastatic urothelial carcinoma
por: Siefker-Radtke, Arlene O, et al.
Publicado: (2022) -
Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate
por: Kokorovic, Andrea, et al.
Publicado: (2021) -
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
por: Siddiqui, Bilal A, et al.
Publicado: (2021) -
Long‐term renal functional outcomes following ureteroureterostomy performed during multi‐organ resection for non‐urothelial cancers
por: Pisters, Phillip W., et al.
Publicado: (2021) -
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
por: Jayaratna, Isuru S., et al.
Publicado: (2015)